- Type / Class
- Equity / Common Stock
- Shares outstanding
- 50,156,118
- Total 13F shares
- 25,772,189
- Share change
- -436,083
- Total reported value
- $641,392,329
- Put/Call ratio
- 6.2%
- Price per share
- $24.88
- Number of holders
- 161
- Value change
- -$15,342,979
- Number of buys
- 84
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 03763A207?
CUSIP 03763A207 identifies ASTH - Astrana Health, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03763A207:
Top shareholders of ASTH - Astrana Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Albert WaiChow Young |
3/4/5
|
Chief Administrative Officer |
—
class O/S missing
|
11,376,409
|
$380,995,937 | — | 02 Dec 2022 | |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp |
3/4/5
13D/G
|
10%+ Owner · Allied Physicians of California, a Professional Medical Corporation |
11%
from 13D/G
|
6,132,802
|
$232,801,164 | — | 15 Feb 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
12%
from 13D/G
|
6,282,943
|
$194,834,070 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.8%
|
4,898,992
|
$151,917,742 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
1,600,298
|
$49,625,241 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
3%
|
1,529,651
|
$47,434,476 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
1,117,767
|
$34,660,188 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
1,067,141
|
$33,099,180 | — | 31 Mar 2025 | |
| 325 CAPITAL LLC |
13F
|
Company |
1.8%
|
886,916
|
$27,503,265 | — | 31 Mar 2025 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
1.1%
|
568,176
|
$17,619,138 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
499,529
|
$15,490,394 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.92%
|
460,802
|
$14,289,469 | — | 31 Mar 2025 | |
| NorthCrest Asset Manangement, LLC |
13F
|
Company |
0.9%
|
448,912
|
$13,920,761 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.68%
|
343,309
|
$10,646,022 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.58%
|
292,043
|
$9,056,253 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.58%
|
290,707
|
$9,014,824 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.56%
|
280,299
|
$8,692,072 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.56%
|
278,619
|
$8,640,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
277,276
|
$8,598,329 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
253,252
|
$7,853,353 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.47%
|
237,926
|
$7,378,085 | — | 31 Mar 2025 | |
| Atria Wealth Solutions, Inc. |
13F
|
Company |
0.47%
|
237,370
|
$7,360,844 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.44%
|
221,896
|
$6,880,995 | — | 31 Mar 2025 | |
| DIAMOND HILL CAPITAL MANAGEMENT INC |
13F
|
Company |
0.42%
|
211,038
|
$6,544,288 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.38%
|
188,700
|
$5,851,587 | — | 31 Mar 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
179,420
|
$5,563,814 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.33%
|
163,155
|
$5,059,437 | — | 31 Mar 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.3%
|
150,000
|
$4,651,500 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.26%
|
131,811
|
$4,087,459 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.24%
|
121,569
|
$3,769,856 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
121,212
|
$3,758,784 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.23%
|
114,807
|
$3,560,143 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
108,638
|
$3,368,865 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.21%
|
104,106
|
$3,228,327 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
100,478
|
$3,115,822 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
92,613
|
$2,871,929 | — | 31 Mar 2025 | |
| Westmount Partners, LLC |
13F
|
Company |
0.18%
|
87,889
|
$2,725,438 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.17%
|
87,244
|
$2,705,436 | — | 31 Mar 2025 | |
| HUSSMAN STRATEGIC ADVISORS, INC. |
13F
|
Company |
0.17%
|
84,000
|
$2,604,840 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.16%
|
82,397
|
$2,555,131 | — | 31 Mar 2025 | |
| F/m Investments LLC |
13F
|
Company |
0.15%
|
73,115
|
$2,267,296 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.14%
|
70,171
|
$2,176,003 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.14%
|
68,909
|
$2,136,868 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
64,288
|
$1,993,570 | — | 31 Mar 2025 | |
| E. Ohman J:or Asset Management AB |
13F
|
Company |
0.12%
|
61,300
|
$1,900,913 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.12%
|
57,909
|
$1,795,758 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
56,153
|
$1,741,305 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.08%
|
40,965
|
$1,668,303 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
50,500
|
$1,566,005 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.09%
|
44,586
|
$1,382,612 | — | 31 Mar 2025 |
Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH) as of Q2 2025
As of 30 Jun 2025,
Astrana Health, Inc. - Common Stock (ASTH) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,772,189 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, 325 CAPITAL LLC, SteelPeak Wealth, LLC, MORGAN STANLEY, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
168
Q2 2025 holders
161
Holder diff
-7
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.